RE:RE:News - Private Placement $12MBayMedica is a revenue-stage biotechnology company, so I would think they will eventually be reporting revenues once the deal is finalized. It might a dilutive acquisition but it might just be a very smart strategic move. Willow does not have the same yield results (5g/L) is certainly not GMP.